American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Lynch Syndrome

Gastroenterology

Volumn 149, Issue 3, 2015, Pages 777-782

  Rubenstein, Joel H ^a,b   Enns, Robert ^c   Heidelbaugh, Joel ^b   Barkun, Alan ^d   Adams, Megan A ^e   Dorn, Spencer D ^e   Dudley Brown, Sharon L ^e   Flamm, Steven L ^e   Gellad, Ziad F ^e   Gruss, Claudia B ^e   Kosinski, Lawrence R ^e   Lim, Joseph K ^e   Romero, Yvonne ^e   Smalley, Walter E ^e   Sultan, Shahnaz ^e   Weinberg, David S ^e   Yang, Yu Xiao ^e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; CANCER DIAGNOSIS; CANCER PREVENTION; COST EFFECTIVENESS ANALYSIS; DECISION SUPPORT SYSTEM; GENE MUTATION; GENETIC SCREENING; HEALTH CARE PERSONNEL; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MICROSATELLITE INSTABILITY; OBSERVATIONAL STUDY; PATIENT PREFERENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROMOTER REGION; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; GASTROENTEROLOGY; GENETIC PREDISPOSITION; GENETICS; PHENOTYPE; PREDICTIVE VALUE; RISK FACTOR; STANDARDS; TREATMENT OUTCOME;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DECISION SUPPORT TECHNIQUES; GASTROENTEROLOGY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84939799233     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.07.036     Document Type: Article

References (7)

1. S. Sultan, Y. Falck-Ytter, and J.M. Inadomi The AGA institute process for developing clinical practice guidelines part one: grading the evidence Clin Gastroenterol Hepatol 11 2013 329 332
2. S. Sultan, Y. Falck-Ytter, and J.M. Inadomi The AGA Institute process for developing clinical practice guidelines part one: grading the evidence Clin Gastroenterol Hepatol 11 2013 329 332
3. R. Graham, M. Mancher, D.M. Wolman, and et al. Clinical practice guidelines we can trust 2011 Institute of Medicine; The National Academies Press Washington, DC
4. U. Ladabaum, J.M. Ford, M. Martel, and et al. American Gastroenterological Association technical review on diagnosis and management of Lynch syndrome Gastroenterology 149 2015 783 812
5. F.M. Giardiello, J.I. Allen, J.E. Axilbund, and et al. Guidelines on genetic evaluation and management of Lynch Syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer Gastroenterology 147 2014 502 526
6. T.A. Dinh, B.I. Rosner, J.C. Atwood, and et al. Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population Cancer Prev Res (Phila) 4 2011 9 22
7. J. Burn, A.-M. Gerdes, F. Macrae, and et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial Lancet 378 2011 2081 2087